Patent applications published 28 April 2010

Published: 28-May-2010

Selected patent applications from the weekly European Patents Bulletin


  • Treatments of B-cell proliferative disorders
    Combinatorx 2178369*

  • Combinations for the treatment of B-cell proliferative disorders
    Combinatorx 2178370*

  • Heterocyclic receptors of cannabinoid receptors
    Board of Regents, The University of Texas System 2178371*

  • Natural bioactive compounds
    Aquapharm Bio-Discovery 2178372*

  • Heterocycles as potassium channel modulators
    Icagen 2178373*

  • Methods of controlling algae with thaxtomin and thaxtomin compsns
    Novozymes Biologicals 2178374*

  • Pyrazol-[1,5-A]-pyrimidine derivative
    Merck Sharp & Dohme 2178375*

  • Lupane-type triterpenoids modified at 30-position and analogues thereof
    Advanced Life Sciences 2178376*

  • Method of combating human head lice
    Nettforsk 2178377*

  • Method of combating sea lice
    Nettforsk 2178378*

  • Materials and methods for delivering compsns to selected tissues
    The Regents of the University of California 2178499*

  • Dry-powder medicament
    Norton Healthcare 2178500*

  • Pharmaceutical preparations comprising electrochemically activated hypochlorite solutions
    Azad Pharma 2178501*

  • Sustained delivery of drugs from biodegradable polymeric microparticles
    Yale University; University of Iowa Research Foundation 2178502*

  • Oral pharmaceutical solutions containing telbivudine
    Novartis 2178503*

  • Preservative-free prostaglandin-based ophthalmic solution
    Laboratoires THEA 2178504*

  • Compsns and methods for wound healing
    University of Massachusetts Medical School 2178505*

  • Preparation of compsns with essentially noncrystalline embedded macrolide antibiotics
    Abbott 2178506*

  • Pharmaceutical compsn comprising solifenacin or a pharmaceutically acceptable salt thereof
    Ratiopharm 2178507*

  • Stable formulations of thiadiazole derivative
    Eli Lilly; Kyowa Hakko Kirin 2178508*

  • Nucleic acid-lipopolymer compsns
    Egen 2178509*

  • Stable solid pharmaceutical compsn comprising candesartan or pharmaceutically acceptable forms thereof
    KRKA 2178510*

  • Tableted compsns containing atazanavir
    Bristol-Myers Squibb 2178511*

  • Tableted compsns containing atazanavir
    Bristol-Myers Squibb 2178512*

  • Tableted compsns containing atazanavir
    Bristol-Myers Squibb 2178513*

  • Film coating compsns based on tribasic calcium phosphate
    Ideal Cures 2178514*

  • Stable compsns
    Generics [UK] 2178515*

  • Pharmaceutical compsn comprising 11-deoxy-prostaglandin compound and method for stabilising the compound
    R-Tech Ueno 2178516*

  • Copolymer-stabilised emulsions
    The Regents of the University of California 2178517*

  • Nanoparticles comprising ionisable, poorly water-soluble cellulosic polymers
    Bend Research 2178518*

  • Nanoparticles comprising a non-ionisable polymer and an anionic cellulosic polymer
    Bend Research 2178519*

  • Drug formulations having inert sealed cores
    Mylan Pharmaceuticals 2178520*

  • Stable medicated chewing gum containing cyclodextrin inclusion complex
    Fertin Pharma 2178521*

  • Compressed chewing gun tablet comprising taste-masking agent
    Fertin Pharma 2178522*

  • Transdermal therapeutic systems which contain the substance anastrozole
    Bratter, Christian 2178523*

  • Microneedle arrays formed from polymer films
    Transderm 2178524*

  • Resveratrol complex and process for the preparation
    Uniao Brasileira De Educaçao E Assistência-Mantenedora Da Pucrs 2178525*

  • Injectable pharmaceutical compsns containing panthenol
    Prototype Bioforum 2178526*

  • Method for activating regulatory T-cells
    IMTM 2178527*

  • Stabilised tolterodine tartrate formulations
    Mylan Pharmaceuticals 2178528*

  • Novel application of topical anaesthetics for modulation of neurogenic tremor
    Zasler, Nathan; Carpenter, Jeffrey 2178529*

  • Medical device and use of pharmaceutical compsn
    Biomet Deutschland 2178530*

  • Methods, compsn, targets for combinatorial cancer treatments
    Yu, Ming 2178531*

  • Anti-bacterial drug targeting of genome maintenance interfaces
    Wisconsin Alumni Research Foundation 2178532*

  • Antiviral compsn comprising a sulphated polysaccharide
    Marinomed Biotechnologie 2178533*

  • Soluble epoxide hydrolase inhibitors, compsns containing such compounds and methods of treatment
    Merck Sharp & Dohme 2178534*

  • Compsns and methods for modulating endophthalmitus using fluoroquinolones
    Bausch & Lomb 2178535*

  • Methods of affecting gastrointestinal transit and gastric emptying, and compounds useful therein
    Lexicon Pharmaceuticals 2178536*

  • Beta carboline as antidiabetic compounds
    Merck Sharp & Dohme 2178537*

  • Anti-inflammatory dermatological compsn containing corticosteroids and hyaluronate fragments, and uses thereof
    Pierre Fabre Dermo-Cosmétique 2178538*

  • Compsns comprising phospholipids
    Murray Goulburn Co-Operative 2178539*

  • Pharmaceutical compsn suitable for adsorption to the cell surface of pathogenic molecules
    Hjertén, Stellan; Hjertén, Marie-Christine; Wadström, Torkel 2178540*

  • Polyacetal-carboxylic acids in the treatment of cancer and autoimmune disorders
    Katholieke Universiteit Leuven 2178542*

  • Lactobacillus rhamnosus and weight control
    Nestec 2178543*

  • Fraction of Melissa leaf extract having angiogenesis and MMP inhibitory activities, and compsn comprising the same
    Angiolab; Kim, Min-Young 2178545*

  • Herbal blood formulations for controlling blood glucose levels in patients with diabetes
    ATP Marketing & Promotion 2178546*

  • Pharmaceutical polypeptide dry powder aerosol formulation and method of preparation
    Aerovance 2178547*

  • Survivin peptides as cancer vaccines
    Health Research 2178548*

  • Antimicrobial peptide, compsns, and methods of use
    Revance Therapeutics 2178549*

  • Methods and compsns for stimulating the proliferation or differentiation of stem cells with substance P or an analogue thereof
    Immuneregen Biosciences 2178550*

  • Novel peptides with anti-tumour activity
    Sanare Investment 2178551*

  • The use of type-B antibiotic-based compounds having antimicrobial activity
    Novacta Biosystems 2178552*

  • Use of a granulin or a granulin-like compound in the therapy or prophylaxis of chronic pains
    Johann Wolfgang Goethe-Universität Frankfurt am Main 2178553*

  • Treating or ameliorating a neuroinflammatory or demyelinating disorder with prolactin and interferon-8
    Stem Cell Therapeutics 2178554*

  • Albumin for treating cancer and a pharmaceutical compsn comprising the combination of an antineoplastic agent and albumin
    Medestea Research & Production 2178555*

  • Protein C for use in maintaining haemostasis
    Oregon Health & Science University; The Scripps Research Institute 2178556*

  • Compsn of tumour-associated peptides and related anti-cancer vaccine
    Immatics Biotechnologies 2178557*

  • Yersinia pestis antigens, vaccine compsns and related methods
    Fraunhofer USA 2178558*

  • Recombinant Vibrio cholerae exo-toxins
    The General Hospital Corp 2178559*

  • Chimeric HIV antigens
    Maxygen 2178560*

  • Antibodies to CD200 and uses thereof in inhibiting immune responses
    Alexion Pharmaceuticals 2178561*

  • Synergistic combinations of VR-1 antagonists and COX-2 inhibitors
    Novartis 2178562*

  • Combination anti-cancer therapy comprising and inhibitor of both MTORC1 and MTORC2 OSI Pharmaceuticals 2178563*

  • Pharmaceutical formulation for delivery of receptor tyrosine kinase inhibiting (RTKI) compounds to the eye
    Alcon 2178564*

  • Complexes between an amphiphilic polymer and an osteogenic protein of the BMPS family
    Adocia 2178565*

  • A conjugate of an antibody against CD4 and antifusogenic peptides
    F Hoffmann-La Roche 2178566*

  • Stabilised immune-modulatory RNA (SIMRA) compounds
    Idera Pharmaceuticals 2178567*

Trending Articles

You may also like